TOFATAS XR 11 TAB 10'S

About

TOFATAS XR 11 TAB is an extended-release formulation of a Janus kinase (JAK) inhibitor, primarily used in the treatment of various autoimmune diseases. It works by selectively inhibiting the activity of specific JAK enzymes, which are crucial in the signaling pathways of cytokines involved in inflammation and immune responses. By blocking these pathways, TOFATAS XR 11 TAB helps to reduce inflammation, alleviate pain, and slow the progression of joint damage in conditions like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The extended-release formulation allows for once-daily dosing, improving patient adherence and maintaining consistent drug levels.

This targeted therapy represents a significant advancement in the management of chronic inflammatory conditions, offering an alternative for patients who have not responded adequately to conventional treatments. Its immunomodulatory effects are potent, but also necessitate careful monitoring for potential side effects, including an increased risk of infections, hematological abnormalities, and cardiovascular events. Regular clinical assessments and laboratory tests are essential to ensure the safe and effective use of TOFATAS XR 11 TAB, optimizing therapeutic benefits while mitigating risks.

Uses

• Treatment of moderate to severe rheumatoid arthritis.
• Management of active psoriatic arthritis.
• Treatment of moderate to severe ulcerative colitis.
• Management of ankylosing spondylitis.

Directions For Use

Take TOFATAS XR 11 TAB once daily, with or without food, as prescribed by your doctor. Swallow the tablet whole; do not crush, cut, or chew.

Benefits

• Effectively reduces inflammation and pain in autoimmune diseases.
• Slows the progression of joint damage in arthritis.
• Provides a targeted approach to immune modulation.
• Convenient once-daily extended-release formulation.
• Offers an alternative for patients unresponsive to other therapies.
• Improves quality of life for patients with chronic conditions.

Side Effects

• Upper respiratory tract infections
• Headache
• Diarrhea
• Nausea
• Nasopharyngitis
• Increased cholesterol levels
• Anemia
• Increased risk of serious infections
• Herpes zoster reactivation
• Lymphopenia
• Neutropenia
• Liver enzyme elevations

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may increase the risk of liver enzyme elevations; consult your doctor.
• Pregnancy - TOFATAS XR 11 TAB is not recommended during pregnancy due to potential risks to the fetus; effective contraception is advised during treatment and for a period after.
• Breastfeeding - Breastfeeding is not recommended while taking TOFATAS XR 11 TAB, as the drug may pass into breast milk and potentially harm the infant.
• Liver - Use with caution in patients with liver impairment; monitor liver function tests regularly, and dose adjustments may be necessary.
• Kidney - Dose adjustments are typically required in patients with moderate to severe kidney impairment; monitor renal function closely.
• Lung - Use with caution in patients with pre-existing lung conditions, as there is a potential for increased risk of serious infections, including opportunistic infections.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.